This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
February 19, 2020
Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and Abingworth
February 19, 2020
BONESUPPORT HOLDING AB (publ) – Full Year Report 2019 – invitation to conference call and webcast
February 19, 2020
Invitation – Orexo Capital Markets Day, Stockholm, Sweden, March 17
February 19, 2020
Q4 2019 General Market Overview
February 17, 2020
Orexo AB (publ.) has resolved to carry out repurchases of own shares
February 12, 2020
Change in the management team
January 31, 2020
BONESUPPORT HOLDING AB signs an agreement on a working capital facility of SEK 60 million
January 30, 2020
Aprea Therapeutics Receives FDA Breakthrough Therapy Designation for APR-246 in Combination with Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) with a TP53 Mutation
January 30, 2020
Q4 incl. Full Year Report 2019
January 29, 2020
Promising results from human PK study assessing novel ketorolac formulations for treatment of pain